Skip to Content
Merck
CN
  • Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy.

Case of fatal Blastoschizomyces capitatus infection occurring in a patient receiving empiric micafungin therapy.

Antimicrobial agents and chemotherapy (2009-09-10)
Paul Chittick, Elizabeth L Palavecino, Brian Delashmitt, James Evans, James E Peacock
ABSTRACT

We report the first case, to our knowledge, of Blastoschizomyces capitatus infection occurring in a patient receiving empirical echinocandin therapy for neutropenic fevers. Clinicians should consider B. capitatus infection in those neutropenic patients who remain febrile despite echinocandin therapy or who develop yeast bloodstream infections while receiving an echinocandin.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
5-Fluorocytosine, nucleoside analog